Shivani Mittra

707 total citations
25 papers, 571 citations indexed

About

Shivani Mittra is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Shivani Mittra has authored 25 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Shivani Mittra's work include Diabetes Treatment and Management (6 papers), Neuropeptides and Animal Physiology (4 papers) and Peptidase Inhibition and Analysis (3 papers). Shivani Mittra is often cited by papers focused on Diabetes Treatment and Management (6 papers), Neuropeptides and Animal Physiology (4 papers) and Peptidase Inhibition and Analysis (3 papers). Shivani Mittra collaborates with scholars based in India, Hong Kong and United Kingdom. Shivani Mittra's co-authors include S. B. Lall, Anita Chugh, Baskaran Thyagarajan, Vinay S. Bansal, Manjeet Singh, Sharda Shah Peshin, Pradip K. Bhatnagar, Kenneth M. Taylor, Subhasis Roy and Jitendra A. Sattigeri and has published in prestigious journals such as British Journal of Pharmacology, Cardiovascular Research and Life Sciences.

In The Last Decade

Shivani Mittra

24 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shivani Mittra India 16 146 139 108 107 104 25 571
Serdar Erkasap Türkiye 14 180 1.2× 137 1.0× 38 0.4× 50 0.5× 30 0.3× 32 639
Shiuh‐Inn Liu Taiwan 20 374 2.6× 246 1.8× 89 0.8× 24 0.2× 72 0.7× 58 937
Ivan Rubio‐Gayosso Mexico 15 79 0.5× 174 1.3× 26 0.2× 43 0.4× 173 1.7× 36 783
Kang‐Ju Chou Taiwan 11 68 0.5× 123 0.9× 51 0.5× 47 0.4× 20 0.2× 35 468
Masami Ohmori Japan 14 98 0.7× 110 0.8× 19 0.2× 36 0.3× 52 0.5× 38 558
Renzo Schiavon Italy 18 125 0.9× 81 0.6× 13 0.1× 98 0.9× 81 0.8× 40 815
Guangtian Yang China 13 39 0.3× 197 1.4× 56 0.5× 42 0.4× 42 0.4× 33 476
Madhusudanarao Vuda Switzerland 14 79 0.5× 290 2.1× 22 0.2× 27 0.3× 28 0.3× 18 642
Huaihong Chen China 14 56 0.4× 239 1.7× 23 0.2× 34 0.3× 28 0.3× 35 567
S. De Luca Italy 15 104 0.7× 207 1.5× 16 0.1× 21 0.2× 102 1.0× 46 908

Countries citing papers authored by Shivani Mittra

Since Specialization
Citations

This map shows the geographic impact of Shivani Mittra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shivani Mittra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shivani Mittra more than expected).

Fields of papers citing papers by Shivani Mittra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shivani Mittra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shivani Mittra. The network helps show where Shivani Mittra may publish in the future.

Co-authorship network of co-authors of Shivani Mittra

This figure shows the co-authorship network connecting the top 25 collaborators of Shivani Mittra. A scholar is included among the top collaborators of Shivani Mittra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shivani Mittra. Shivani Mittra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paul, Pritha, et al.. (2024). Increasing adoption of quality-assured biosimilars to address access challenges in low- and middle-income countries. Generics and Biosimilars Initiative Journal. 13(2). 40–54. 1 indexed citations
3.
Mittra, Shivani, et al.. (2023). Biosimilars drug development: time for a paradigm shift?. Generics and Biosimilars Initiative Journal. 12(1). 17–22. 2 indexed citations
5.
Mittra, Shivani, et al.. (2023). Ethnic sensitivity assessments in biosimilar monoclonal antibodies clinical development programmes: necessary or not?. Generics and Biosimilars Initiative Journal. 12(2). 61–66. 3 indexed citations
6.
Mittra, Shivani, et al.. (2022). IDF21-0380 An integrated diabetes ecosystem to address patient barriers in low-income communities in Philippines. Diabetes Research and Clinical Practice. 186. 109614–109614.
7.
Sharma, Suchitra, et al.. (2012). Antihyperglycemic effect of Annona squamosa hexane extract in type 2 diabetes animal model: PTP1B inhibition, a possible mechanism of action?. Indian Journal of Pharmacology. 44(3). 326–326. 29 indexed citations
8.
Roy, Subhasis, et al.. (2012). Biological evaluation of RBx-0128, a potent and selective dipeptidyl peptidase-IV inhibitor in type 2 diabetes genetic model. Indian Journal of Pharmacology. 44(6). 759–759. 2 indexed citations
9.
Roy, Subhasis, et al.. (2010). Nature of action of sitagliptin, the dipeptidyl peptidase-IV inhibitor in diabetic animals. Indian Journal of Pharmacology. 42(4). 229–229. 33 indexed citations
10.
Mittra, Shivani, Vinay S. Bansal, & Pradip K. Bhatnagar. (2008). From a glucocentric to a lipocentric approach towards metabolic syndrome. Drug Discovery Today. 13(5-6). 211–218. 34 indexed citations
11.
Khanna, Vivek, et al.. (2007). Topiramate and Type 2 diabetes: an old wine in a new bottle. Expert Opinion on Therapeutic Targets. 12(1). 81–90. 13 indexed citations
12.
Roy, Subhasis, Vivek Khanna, Shivani Mittra, et al.. (2007). Combination of dipeptidylpeptidase IV inhibitor and low dose thiazolidinedione: Preclinical efficacy and safety in db/db mice. Life Sciences. 81(1). 72–79. 16 indexed citations
13.
Mittra, Shivani, Ruchi Tandon, Sumit Sharma, et al.. (2007). Increase in weight induced by muraglitazar, a dual PPARα/γ agonist, in db/db mice: adipogenesis/or oedema?. British Journal of Pharmacology. 150(4). 480–487. 32 indexed citations
14.
Mittra, Shivani, et al.. (2007). Role of peripheral 5-HT1A receptors in detrusor over activity associated with partial bladder outlet obstruction in female rats. European Journal of Pharmacology. 561(1-3). 189–193. 19 indexed citations
15.
Mittra, Shivani, et al.. (2005). Gs and Gi coupling of adrenomedullin in adult rat ventricular myocytes. American Journal of Physiology-Heart and Circulatory Physiology. 290(5). H1842–H1847. 22 indexed citations
16.
Mittra, Shivani, et al.. (2005). Intermittent claudication: An overview. Atherosclerosis. 187(2). 221–237. 89 indexed citations
17.
Mittra, Shivani, et al.. (2004). Role of cyclooxygenase in ventricular effects of adrenomedullin: is adrenomedullin a double-edged sword in sepsis?. American Journal of Physiology-Heart and Circulatory Physiology. 286(3). H1034–H1042. 26 indexed citations
18.
Mittra, Shivani & Manjeet Singh. (1998). Possible mechanism of captopril induced endothelium-dependent relaxation in isolated rabbit aorta. Molecular and Cellular Biochemistry. 183(1-2). 63–67. 38 indexed citations
19.
Mittra, Shivani, et al.. (1997). An experimental study on cardiotoxicity of aluminium phosphide.. PubMed. 35(10). 1060–4. 29 indexed citations
20.
Murray, William R., et al.. (1981). The amylase-creatinine clearance ratio following cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery. 82(2). 248–253. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026